Results 21 to 30 of about 8,379,611 (261)

HAART (Highly Active Anti-Retroviral Therapy) : An overview

Journal of Marine Medical Society, 2014
Highly Active Anti - Retroviral Therapy (HAART) is a triple combination of ART drugs and is a n effective tool to control disease progression in HIV disease.
Praful Pande, Vivek Hande
doaj   +1 more source

Duration of Highly Active Antiretroviral Therapy Regimens [PDF]

Clinical Infectious Diseases, 2003
The median duration of highly active antiretroviral therapy (HAART) regimens was reported to be 11.8 months in one US study, but that study included both treatment-experienced and treatment-naive patients. The duration of initial HAART regimens for treatment-naive patients alone has not been reported.
Ray Y, Chen, Andrew O, Westfall, Michael J, Mugavero, Gretchen A, Cloud, James L, Raper, Ashlee G, Chatham, Edward P, Acosta, Kelly H, Taylor, Jerome, Carter, Michael S, Saag   +9 more
openaire   +2 more sources

Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. [PDF]

, 2012
Increased mortality among men on antiretroviral therapy (ART) has been documented but remains poorly understood.
Giddy, Janet, Lessells Richard, Cornell, Morna, Maskew, Mhairi, Hans Prozesky (138512), Schomaker, Michael, Michael Schomaker (138489), Matthias Egger, Morna Cornell (138484), Robin Wood (4924), Hoffmann, Christopher J, Boulle Andrew, Myer, Landon, Landon Myer, Matthias Egger (24558), Leigh F Johnson, Johnson Leigh F., Christopher J. Hoffmann (138499), Daniela Belen Garone, Prozesky, Hans, Schomaker Michael, Andrew Boulle, Daniela Belen Garone (138494), Wood, Robin, International Epidemiologic Databases to Evaluate AIDS Southern, Mhairi Maskew (138509), Egger, Matthias, Cornell Morna, Hans Prozesky, Egger Matthias, Johnson, Leigh F., Janet Giddy, Prozesky Hans, Johnson, Leigh F, International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration, Garone, Daniela Belen, Andrew Boulle (93997), Robin Wood, Richard Lessells (138505), Giddy Janet, Christopher J Hoffmann, Landon Myer (138517), Maskew Mhairi, Richard Lessells, Hoffmann Christopher J., Lessells, Richard, Leigh F. Johnson (138514), Janet Giddy (25207), International Epidemiologic Databases to Evaluate AIDS Southern,, Hoffmann, Christopher J., Mhairi Maskew, Morna Cornell, Garone Daniela Belen, Wood Robin, Boulle, Andrew, Myer Landon, Michael Schomaker   +56 more
core   +2 more sources

Antiretroviral agents against human immunodeficiency virus

DST, 2022
Introduction: Since its discovery in the 1980s, the human immunodeficiency virus (HIV) has been the target of many studies. Nowadays, estimates show that 36.7 million people are infected with HIV worldwide.
Ingrid Barcelos de Oliveira, Claudio Cesar Cirne Santos, Izabel Christina Nunes de Palmer Paixão, Caroline de Souza Barros, Rosa Teixeira Pinho   +4 more
doaj  

Highly Active Antiretroviral Therapy (HAART) [PDF]

Journal of Ethiopian Medical Practice, 2001
No Abstract. Journal of Ethiopian Medical Journal Vol. 3(2) 2002: pp.
Daniel Thomas Ginat, Pamela Whitney Schaefer   +1 more
openaire   +3 more sources

Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006–2020

BMC Infectious Diseases, 2023
Background To estimate crude mortality, excess mortality, and standardized mortality rates (SMR) among people living with HIV (PLHIV) initiating highly active antiretroviral therapy (HAART) in Luzhou, China 2006–2020, and assess associated factors ...
Dandan Niu, Ticheng Xiao, Yuanyi Chen, Houlin Tang, Fangfang Chen, Chang Cai, Qianqian Qin, Decai Zhao, Yichen Jin, Shi Wang, Yushan Hou, Zhen Lu, Luoyao Yang, Hong Liu, Dongqin Xie, Huachun Zou, Fan Lyu   +16 more
doaj   +1 more source

Daily Dosing of Highly Active Antiretroviral Therapy [PDF]

Clinical Infectious Diseases, 2002
Complex treatment schedules for human immunodeficiency virus (HIV) disease, which can have a high pill burden and can include multiple daily doses, in addition to the adverse effects that the medications can cause, may reduce patient adherence to therapy. Reduced adherence prevents achievement of the desired goal of full suppression of HIV replication,
Keith A, Rosenbach, Robert, Allison, Jeffrey P, Nadler   +2 more
openaire   +2 more sources

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy [PDF]

, 2005
Background. Very low rates of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) are achievable with use of highly active antiretroviral therapy (HAART).
Canet, Y, SCHERPBIER H, FORTUNY C, Masuelli, G, Bates, I, A. Ehrnst, BUFFOLANO W, Barlow, P, Caro, MC, SUY A, J. Ma Pena, D. Perez-Tamarit, F. Hawkins, A. Suy, MARTINELLI P, SUAREZ G, Bohlin, AB, EHRNST A, DE MARIA A, Sansone, M, A. De Maria, LIDMAN K, Penn, Z, N. H. Valerius, HAINAUT M, KREYENBROEK M, R. Carreras, R. Tiseo, RABUSIN M, JIMENEZ J, DE JOSE I, Y. Canet, E. G. H. Lyall, Alberico, S, VALERIUS NH, Bernardon, M, Pena, JM, Ferrazi, E, Otero, MC, LOPEZ VILCHEZ MA, E. Ferrazzi, CARRERAS R, I. Bates, Taylor, GP, BOER K, P. Martinelli, M. Rabusin, Mok, J, LEVY J, Bassetti, D, A. Ferrazin, AGANGI A, Ruga, E, de Jose, I, BARLOW P, A. Mur, I. Grosch-Worner, Ferrazin, A, Garcia-Rodriguez, MC, Naver, L, FERRAZI E, ALBERICO S, M. Hainaut, M. Casellas Caro, MOK J, ASENSI BOTET F, Jimenez, J, A. Horban, Fortuny, C, G. P. Taylor, M. Kreyenbroek, GARCIA JG, HAWKINS F, A. De Rossi, COLL O, GOTTA C, Levy, J, Lindgren, S, PAYA A, Ehrnst, A, TAYLOR GP, Asensi-Botet, F, SANSONE M, M. Vinolas, Vinolas, M, Tiseo, R, J. Gonzalez Garcia, M. Bernardon, GOETGHEBUER T, NAVER L, Scherpbier, H, SAVASI V, et al, LOPEZ JRA, F. Asensi-Botet, C. Tibaldi, TIBALDI C, Coll, O, Garcia, JG, Marczynska, M, A. B. Bohlin, I. de Jose, TISEO R, PENN Z, De Rossi, A, Hainaut, M, Gotta, C, PEREZ TAMARIT DP, J. R. Arribas Lopez, RUGA, EZIA MARIA, C. Benedetto, T. Goetghebuer, MUR A, BOHLIN AB, Giaquinto, C, J. Mok, Goetghebuer, T, S. Marini, Carreras, R, OTERO MC, S. Lindgren, CANET Y, K. Boer, A. Viganò, Belfrage, E, GIAQUINTO, CARLO, H. Scherpbier, Valerius, NH, D. Bassetti, Anzen, B, LINDGREN S, Lopez-Vilchez, MA, BASSETTI D, V. Savasi, Kreyenbroek, M, Marini, S, Peltier, A, M. C. Garcia-Rodriguez, C. Ladron de Guevara, W. Buffolano, LYALL EGH, Mur, A, J. Levy, de Guevara, CL, DE ROSSI, ANITA, CARO MC, Z. Penn, ANZEN B, Hawkins, F, GROSCH WORNER I, VINOLAS M, C. Giaquinto, Grosch-Worner, I, Niemiec, T, J. Jimenez, B. Anzen, Suarez, G, Martinelli, P, Paya, A, O. Coll, J. M. Perez, G. Masuelli, Boer, K, Buffolano, W, M. A. Lopez-Vilchez, BELFRAGE E, Rovira, Perez-Tamarit, DP, Lidman, K, C. Gotta, E. Ruga, VIGANO A, M. Sansone, E. Belfrage, Tibaldi, C, DE GUEVARA CL, S. Alberico, BATES I, Perez, JM, A. Peltier, P. Barlow, A. Paya, PELTIER A, G. Suarez, FERRAZIN A, Lopez, JRA, Vigano, A, Agangi, A, PENA JM, K. Lidman, Horban, A, C. Fortuny, M. C. Otero, A. Agangi, De Maria, A, BERNARDON M, GARCIA RODRIGUEZ MC, T. Niemiec ̧ M. Marczynskam, Benedetto, C, Rabusin, M, Suy, A, Lyall, EGH, PEREZ JM, L. Naver, Savasi, V   +204 more
core   +1 more source

Highly active antiretroviral therapy: Does it Sound toxic?

Journal of Pharmacy and Bioallied Sciences, 2011
Objective : The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic
Katijah Khoza-Shangase
doaj   +1 more source

Update on highly active antiretroviral therapy: progress and strategies [PDF]

Biomedicine & Pharmacotherapy, 2000
HIV patients who have detectable viral loads (1,000-5,000 copies/mL) and/or evidence of immunologic dysfunction (CD4+ T-lymphocyte count < 500/mm3) should be treated with a potent combination antiretroviral regimen. Currently, this is to consist of two nucleoside reverse transcriptase inhibitors (NRTIs) with at least one protease inhibitor (PI), or a ...
Clumeck, Nathan, De Wit, Stéphane
openaire   +2 more sources